Orion Pharma Limited (DSE:ORIONPHARM)

Orion Pharma Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	73.54	147.73	130.11	106.13	414.99	1,034
Short-Term Investments	61.7	45.82	38.68	31.83	23.62	19.58
Cash & Short-Term Investments	135.24	193.55	168.79	137.97	438.61	1,054
Cash Growth	-46.09%	14.67%	22.34%	-68.54%	-58.38%	911.13%
Accounts Receivable	14,411	4,210	5,584	6,796	3,943	2,662
Other Receivables	-	9,706	9,811	8,109	8,458	8,987
Receivables	14,411	13,916	15,395	14,905	12,401	11,649
Inventory	1,641	1,699	1,614	1,660	1,411	1,278
Prepaid Expenses	-	0.11	1.1	26.19	43.84	44.52
Other Current Assets	911.95	1,045	1,897	2,026	1,928	3,722
Total Current Assets	17,098	16,853	19,076	18,755	16,223	17,747
Property, Plant & Equipment	29,884	28,265	26,424	23,009	19,856	16,633
Long-Term Investments	7,670	8,067	7,440	6,343	6,254	2,462
Other Long-Term Assets	-	-	-	-	-	-0
Total Assets	54,652	53,186	52,940	48,107	42,333	36,841
Accounts Payable	7,129	5,097	6,259	7,301	4,231	2,619
Accrued Expenses	624.04	298.44	270.03	265.44	232.48	225.55
Short-Term Debt	546.95	556.18	547.82	563.9	564.32	566
Current Portion of Long-Term Debt	-	67.35	490.5	387.47	274.33	201.88
Current Portion of Leases	15.41	13.94	23.91	31.66	36.42	38.35
Current Income Taxes Payable	-	304.49	435.26	398.62	262.75	197.86
Other Current Liabilities	284.88	1,429	1,444	488.23	406.06	599.16
Total Current Liabilities	8,600	7,766	9,470	9,437	6,008	4,447
Long-Term Debt	23,138	21,864	20,808	17,601	15,930	12,871
Long-Term Leases	31.5	13.71	26.35	35.27	39.9	46.91
Long-Term Deferred Tax Liabilities	379.85	315.43	157.7	122.25	138.28	142.61
Other Long-Term Liabilities	143.41	143.41	143.41	143.41	143.41	143.41
Total Liabilities	32,293	30,103	30,606	27,338	22,259	17,651
Common Stock	2,340	2,340	2,340	2,340	2,340	2,340
Additional Paid-In Capital	8,017	8,017	8,017	8,017	8,017	8,017
Retained Earnings	7,230	7,499	7,400	6,978	6,401	5,670
Comprehensive Income & Other	3,281	3,683	3,067	1,978	1,905	1,937
Total Common Equity	20,868	21,540	20,824	19,313	18,663	17,964
Minority Interest	1,491	1,543	1,510	1,456	1,412	1,226
Shareholders' Equity	22,359	23,083	22,334	20,769	20,074	19,190
Total Liabilities & Equity	54,652	53,186	52,940	48,107	42,333	36,841
Total Debt	23,732	22,515	21,897	18,619	16,844	13,724
Net Cash (Debt)	-23,596	-22,305	-21,700	-18,446	-16,377	-12,647
Net Cash Per Share	-100.84	-95.32	-92.74	-78.83	-69.99	-54.05
Filing Date Shares Outstanding	234	234	234	234	234	234
Total Common Shares Outstanding	234	234	234	234	234	234
Working Capital	8,498	9,087	9,606	9,318	10,216	13,299
Book Value Per Share	89.18	92.05	88.99	82.53	79.76	76.77
Tangible Book Value	20,868	21,540	20,824	19,313	18,663	17,964
Tangible Book Value Per Share	89.18	92.05	88.99	82.53	79.76	76.77

Updated Feb 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.